Skip to main content Skip to main content
VitalDecades logo VitalDecades

Pillar / Heart health

Heart health

Blood pressure, lipids, ApoB and inflammation markers: the numbers, the thresholds and how to track them.

10 guides · last checked

Figure: Blood pressure: the categories and what they trigger. Normal: below 120 over 80. Elevated: 120 to 129 systolic with a diastolic below 80. Stage 1: 130 to 139 or 80 to 89. Stage 2: 140 or above or 90 or above. The treatment goal for almost every adult: below 130 over 80.
The 2025 AHA/ACC blood pressure categories in mm Hg, as this hub restates them from the guideline.

01  /  Start here

Guides, newest first

02  /  Numbers to track

Biomarkers that matter here

Heart health after 40 comes down to a few numbers

Heart health after 40 is mostly a question of a few numbers and what each one triggers. This pillar collects the guides that read those numbers the way the guidelines do: the 2025 blood pressure categories and the treatment decisions attached to each, the cholesterol goals the 2026 guideline sets by risk in place of age (and the retired 2001 categories many readers still see online), the one lipid test worth ordering once in a lifetime, and the trial evidence on walking. Every figure below is restated from the guide it links to, where it carries the primary source and that source's date.

Blood pressure: the categories and what they trigger

The 2025 AHA/ACC guideline keeps the 2017 categories: normal is below 120 over 80, elevated is 120 to 129 systolic with a diastolic below 80, stage 1 is 130 to 139 or 80 to 89, and stage 2 is 140 or above or 90 or above. What changed is the decision rule. Stage 1 means medication alongside lifestyle change if you have cardiovascular disease, a previous stroke, diabetes or chronic kidney disease, or a 10-year risk of 7.5 percent or more on the PREVENT calculator; without those conditions and below that risk, it means a 3 to 6 month trial of lifestyle change first, then medication if the average stays at or above 130 over 80. The treatment goal for almost every adult is below 130 over 80. Blood pressure ranges explained walks through each category, and the blood pressure reference ledger prints the thresholds with their source rows.

Walking has a measured effect size. A 2021 Cochrane review of 73 randomized trials and 5,060 participants found walking lowered systolic pressure by 4.11 mmHg on moderate-certainty evidence, at a dose the review states plainly: moderate intensity, three to five times a week, 20 to 40 minutes a session, for about three months. Does walking lower blood pressure? reports the diastolic and heart-rate figures and the certainty grades behind each.

Cholesterol: the thresholds, and why age is not one of them

No guideline publishes cholesterol targets by decade of age. In the material we could read, the 2026 ACC/AHA dyslipidemia guideline names one LDL category, severe hypercholesterolemia at 190 mg/dL and above, and otherwise sets LDL goals by risk: under 100, under 70 or under 55 mg/dL. Age enters as an input to the calculated risk: for adults 30 to 79 without atherosclerotic cardiovascular disease whose LDL is 70 to 189 mg/dL, the guideline calculates 10-year and 30-year risk with PREVENT-ASCVD. The bands many readers still see online (LDL optimal under 100 mg/dL up to very high at 190 and above, and HDL under 40 as a major risk factor) come from the 2001 NCEP ATP III classification, which NHLBI notes was followed by new ACC/AHA guidelines on November 12, 2013. Cholesterol levels by age explains why the decade charts elsewhere on the web are not from any guideline.

Two guides cover the numbers a standard panel misses. ApoB vs LDL cholesterol explains why ApoB is a count of atherogenic particles rather than a weight of cholesterol, where the two diverge (high triglycerides, insulin resistance, diabetes), and the 2026 guideline's ApoB numbers: 120 mg/dL or higher as a risk enhancer, and optional goals of under 90, 70 or 55 mg/dL by risk group. Lipoprotein(a) levels covers the test the European Atherosclerosis Society says to run at least once in adulthood: the level is genetically set, 50 mg/dL is where it is treated as a risk enhancer, and as of August 2026 no drug is approved to lower it. HDL cholesterol explains why raising a low HDL with a drug stopped being a goal after the AIM-HIGH and torcetrapib trials.

Where to start with your own numbers

Start with your most recent blood pressure and lipid panel. Read the category each number falls in on the biomarker library, then open the guide for the decision that category triggers. If your report has no ApoB or Lp(a) row, the two guides above explain what each would add and who benefits from ordering it once. Nothing here replaces the risk calculation your clinician runs; it is meant to make that conversation shorter and better informed.

Frequently asked questions

Which number matters most after 40?

For most people, no single number decides. The 2025 blood pressure guideline decides stage 1 treatment on your conditions (cardiovascular disease, a previous stroke, diabetes or chronic kidney disease) and your PREVENT 10-year risk, and the 2026 cholesterol guideline decides the statin question for adults 30 to 79 without ASCVD and an LDL of 70 to 189 mg/dL on calculated 10-year PREVENT-ASCVD risk. Two results decide without the calculation: an average blood pressure of 140 over 90 or above, and an LDL of 190 mg/dL or above. ApoB and Lp(a) refine the picture when a standard panel may understate risk.

Do I need cholesterol targets for my age?

No guideline publishes them. The retired 2001 NCEP ATP III categories applied at every adult age. In the 2026 ACC/AHA guideline, age decides who gets a PREVENT-ASCVD risk calculation (adults 30 to 79 without ASCVD and an LDL of 70 to 189 mg/dL), not what the target is; the USPSTF ties its statin recommendation to ages 40 to 75.

Edited by (Managing Editor). How pages are checked